


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:07Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405607" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405607</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="pai70182" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Allergy Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr Allergy Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">PAI</journal-id><journal-title-group><journal-title>Pediatric Allergy and Immunology</journal-title></journal-title-group><issn pub-type="ppub">0905-6157</issn><issn pub-type="epub">1399-3038</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405607</article-id><article-id pub-id-type="pmcid-ver">PMC12405607.1</article-id><article-id pub-id-type="pmcaid">12405607</article-id><article-id pub-id-type="pmcaiid">12405607</article-id><article-id pub-id-type="pmid">40898384</article-id><article-id pub-id-type="doi">10.1111/pai.70182</article-id><article-id pub-id-type="publisher-id">PAI70182</article-id><article-id pub-id-type="other">PAI-25-OGA-0161.R2</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Improving immune&#8208;related health outcomes post&#8208;cesarean birth with a gut microbiome&#8208;based program: A randomized controlled trial</article-title><alt-title alt-title-type="left-running-head">Nieto et&#160;al.</alt-title></title-group><contrib-group><contrib id="pai70182-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Nieto</surname><given-names initials="PA">Pamela A.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-2157-0272</contrib-id><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>pamela@tinyhealth.com</email></address></contrib><contrib id="pai70182-cr-0002" contrib-type="author"><name name-style="western"><surname>Nakama</surname><given-names initials="C">Claudia</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0003" contrib-type="author"><name name-style="western"><surname>Trachsel</surname><given-names initials="J">Julian</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2357-7737</contrib-id><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0004" contrib-type="author"><name name-style="western"><surname>Goad</surname><given-names initials="D">David</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0005" contrib-type="author"><name name-style="western"><surname>Soderborg</surname><given-names initials="TK">Taylor K.</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0006" contrib-type="author"><name name-style="western"><surname>Tan</surname><given-names initials="DS">Danielle Shea</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0007" contrib-type="author"><name name-style="western"><surname>Orlandi</surname><given-names initials="A">Amy</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0008" contrib-type="author"><name name-style="western"><surname>Yuan</surname><given-names initials="Q">Qian</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8639-835X</contrib-id><xref rid="pai70182-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="pai70182-cr-0009" contrib-type="author"><name name-style="western"><surname>Song</surname><given-names initials="E">Elisa</given-names></name><xref rid="pai70182-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="pai70182-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="pai70182-cr-0010" contrib-type="author"><name name-style="western"><surname>Mueller</surname><given-names initials="NT">Noel T.</given-names></name><xref rid="pai70182-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="pai70182-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="pai70182-cr-0011" contrib-type="author"><name name-style="western"><surname>Mars</surname><given-names initials="RA">Ruben A.</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pai70182-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="pai70182-cr-0012" contrib-type="author"><name name-style="western"><surname>Hoy</surname><given-names initials="CS">Cheryl Sew</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70182-cr-0013" contrib-type="author" corresp="yes"><name name-style="western"><surname>Sukhum</surname><given-names initials="KV">Kimberley V.</given-names></name><xref rid="pai70182-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>kimberley@tinyhealth.com</email></address></contrib></contrib-group><aff id="pai70182-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Seeding Inc, Doing Business as Tiny Health</institution>
<city>Austin</city>
<named-content content-type="country-part">Texas</named-content>
<country country="US">USA</country>
</aff><aff id="pai70182-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Food Allergy Center, Massachusetts General Hospital</named-content>
<institution>Harvard Medical School</institution>
<city>Boston</city>
<named-content content-type="country-part">Massachusetts</named-content>
<country country="US">USA</country>
</aff><aff id="pai70182-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Whole Family Wellness</institution>
<city>Belmont</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="pai70182-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Healthy Kids Happy Kids</institution>
<city>Belmont</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="pai70182-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatrics, Section of Nutrition</named-content>
<institution>University of Colorado Anschutz Medical Campus</institution>
<city>Aurora</city>
<named-content content-type="country-part">Colorado</named-content>
<country country="US">USA</country>
</aff><aff id="pai70182-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Epidemiology</named-content>
<institution>Colorado School of Public Health</institution>
<city>Denver</city>
<named-content content-type="country-part">Colorado</named-content>
<country country="US">USA</country>
</aff><aff id="pai70182-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Division of Gastroenterology and Hepatology</named-content>
<institution>Mayo Clinic</institution>
<city>Rochester</city>
<named-content content-type="country-part">Minnesota</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Pamela A. Nieto and Kimberley V. Sukhum, Seeding Inc, Doing Business as Tiny Health, Austin, TX, USA.<break/>
Email: <email>pamela@tinyhealth.com</email> and <email>kimberley@tinyhealth.com</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>36</volume><issue seq="26">9</issue><issue-id pub-id-type="pmc-issue-id">496084</issue-id><issue-id pub-id-type="doi">10.1111/pai.v36.9</issue-id><elocation-id>e70182</elocation-id><history><date date-type="rev-recd"><day>13</day><month>8</month><year>2025</year></date><date date-type="received"><day>10</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 Seeding Inc dba Tiny Health. <italic toggle="yes">Pediatric Allergy and Immunology</italic> published by European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="PAI-36-e70182.pdf"/><self-uri content-type="pdf" xlink:href="file:PAI-36-e70182.pdf"/><abstract><title>Abstract</title><sec id="pai70182-sec-0001"><title>Background</title><p>Infants born via Cesarean section (C&#8208;section) often have a distinct gut microbiome and higher risks of atopic and immune&#8208;related conditions than vaginally delivered infants. We evaluated whether a microbiome&#8208;based program could shift gut microbiome composition and improve microbiome&#8208;associated health outcomes in C&#8208;section born infants.</p></sec><sec id="pai70182-sec-0002"><title>Methods</title><p>This open&#8208;label, randomized, controlled trial included full&#8208;term C&#8208;section&#8208;born infants aged 0&#8211;3&#8201;months, randomized to an intervention (<italic toggle="no">n</italic>&#8201;=&#8201;25) or control arm (<italic toggle="no">n</italic>&#8201;=&#8201;29). Over 6&#8201;months, the intervention arm received two microbiome reports, personalized recommendations based on their microbiome, educational materials, and coaching calls focused on microbiome health. Parents reported health conditions via surveys. Primary outcome: Difference between study arms in relative abundance of key gut microbiome taxa and functional genes. Other outcomes: Changes in a C&#8208;section index&#8212;a taxonomy&#8208;based metric comparing C&#8208;section&#8208;associated taxa to vaginally&#8208;associated taxa&#8212;and prevalence of atopic conditions.</p></sec><sec id="pai70182-sec-0003"><title>Results</title><p>Compared to controls, the intervention arm had higher <italic toggle="no">Bifidobacterium</italic> (<italic toggle="no">p</italic>&#8201;=&#8201;.025, <italic toggle="no">q</italic>&#8201;=&#8201;.121) and higher abundance of genes associated with human milk oligosaccharide degradation (e.g., &#945;&#8208;L&#8208;fucosidase, <italic toggle="no">p</italic>&#8201;=&#8201;.019, <italic toggle="no">q</italic>&#8201;=&#8201;.046) at timepoint 2. In the intervention arm, the C&#8208;section index decreased to a level similar to vaginally born infants (<italic toggle="no">p</italic>&#8201;=&#8201;.807, <italic toggle="no">q</italic>&#8201;=&#8201;.807). At the end of the intervention, atopic dermatitis prevalence was lower in the intervention arm than in controls (odds ratio, 0.17 [95% CI, 0.023&#8211;0.723], <italic toggle="no">p</italic>&#8201;=&#8201;.031).</p></sec><sec id="pai70182-sec-0004"><title>Conclusion</title><p>A personalized microbiome&#8208;based program can modulate the gut microbiome of C&#8208;section&#8208;born infants and may reduce the risk of atopic conditions (<ext-link xlink:href="http://clinicaltrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link>: <ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT06424691">NCT06424691</ext-link>).</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="pai70182-kwd-0001">atopic dermatitis</kwd><kwd id="pai70182-kwd-0002">bifidobacterium</kwd><kwd id="pai70182-kwd-0003">cesarean section</kwd><kwd id="pai70182-kwd-0004">gut</kwd><kwd id="pai70182-kwd-0005">infant gut</kwd><kwd id="pai70182-kwd-0006">microbiome</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Seeding Inc. DBA Tiny Health</institution></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="11"/><word-count count="7000"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:02.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="PAI70182-cit-2001"><string-name name-style="western"><surname>Nieto</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Nakama</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Trachsel</surname><given-names>J</given-names></string-name>, et al. <article-title>Improving immune&#8208;related health outcomes post&#8208;cesarean birth with a gut microbiome&#8208;based program: A randomized controlled trial</article-title>. <source>Pediatr Allergy Immunol</source>. <year>2025</year>;<volume>36</volume>:<elocation-id>e70182</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/pai.70182</pub-id><pub-id pub-id-type="pmid">40898384</pub-id><pub-id pub-id-type="pmcid">PMC12405607</pub-id></mixed-citation>
</p><fn-group id="pai70182-ntgp-0001"><fn id="pai70182-note-0001"><p>
<bold>Editor:</bold> Jon Genuneit</p></fn></fn-group></notes></front><body id="pai70182-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="pai70182-blkfxd-0001" orientation="portrait"><caption><title>Key message</title></caption><p>Cesarean&#8208;born infants often have a distinct gut microbiome and a higher risk of atopic conditions, highlighting the need for early interventions. This study evaluated a personalized microbiome&#8208;based program for these infants, showing modulation of gut microbiome structure and functionality, and lower odds of developing atopic dermatitis. These findings suggest that microbiome&#8208;targeted strategies may help mitigate immune&#8208;related health risks in Cesarean&#8208;born infants, offering a novel approach to early life health optimization.</p></boxed-text>
</p><sec id="pai70182-sec-0007"><label>1</label><title>INTRODUCTION</title><p>The first 1000&#8201;days of life are viewed as a crucial window of immune development, with the gut microbiome playing a key role.<xref rid="pai70182-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="pai70182-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="pai70182-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="pai70182-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> One major factor shaping gut microbiome composition is delivery mode.<xref rid="pai70182-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="pai70182-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="pai70182-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Vaginally&#8208;born infants typically exhibit a higher abundance of <italic toggle="yes">Bifidobacterium</italic>, <italic toggle="yes">Bacteroides</italic>, and <italic toggle="yes">Parabacteroides</italic> compared to those born via C&#8208;section.<xref rid="pai70182-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> These first colonizers often drive human milk oligosaccharide (HMO) degradation, resulting in short&#8208;chain fatty acid (SCFA) production and colonization resistance.<xref rid="pai70182-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="pai70182-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> In contrast, C&#8208;section&#8208;born infants are often colonized by skin and hospital&#8208;associated bacteria, such as <italic toggle="yes">Staphylococcus</italic>,<xref rid="pai70182-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>
<italic toggle="yes">Enterococcus</italic>, <italic toggle="yes">Klebsiella</italic>, and <italic toggle="yes">Clostridium</italic> species.<xref rid="pai70182-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="pai70182-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="pai70182-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> These often lack the ability to degrade HMOs or produce SCFAs and are more likely to harbor antibiotic resistance genes.<xref rid="pai70182-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>
</p><p>A C&#8208;section&#8208;associated microbiome signature can persist in children up to the age of four<xref rid="pai70182-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="pai70182-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> and has been linked to an increased risk of type 1 diabetes,<xref rid="pai70182-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> obesity,<xref rid="pai70182-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="pai70182-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> and atopic march.<xref rid="pai70182-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Atopic march refers to the progression from atopic dermatitis (AD) to food allergies, rhinitis, and asthma,<xref rid="pai70182-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="pai70182-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70182-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> which can lead to chronic allergic and inflammatory diseases later in life.<xref rid="pai70182-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Stokholm et&#160;al. (2020) found that children who retained a C&#8208;section signature at 1&#8201;year had a threefold higher risk of developing asthma by age six.<xref rid="pai70182-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> This stresses the need for strategies to modulate microbiome composition in infants born via C&#8208;section.</p><p>We aimed to evaluate the effectiveness of a gut microbiome&#8208;based program in improving gut health and reducing the risk of health conditions in C&#8208;section&#8208;delivered infants. We hypothesized that participation in the program would shift the composition and functionality of the infant gut microbiome and decrease microbiome signatures of C&#8208;section. Additionally, we examined whether a microbiome&#8208;based intervention reduced the prevalence of parent&#8208;reported infant health conditions such as atopic dermatitis.</p></sec><sec sec-type="methods" id="pai70182-sec-0008"><label>2</label><title>METHODS</title><sec id="pai70182-sec-0009"><label>2.1</label><title>Study design</title><p>We conducted an open label, stratified, randomized [1:1], controlled trial to test the effects of a microbiome&#8208;based intervention versus self&#8208;directed control. Our trial was registered with <ext-link xlink:href="http://clinicaltrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link> (<ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT06424691">NCT06424691</ext-link>). Participants were recruited between August 2023 and November 2023. The trial was completed as planned, with data collection finalized in May 2024. The full trial protocol is available in Appendix&#160;<xref rid="pai70182-supitem-0001" ref-type="supplementary-material">S1</xref>, with no significant changes after commencement.</p></sec><sec id="pai70182-sec-0010"><label>2.2</label><title>Setting and population</title><p>Major inclusion criteria included: infants born at full term (&#8805;36&#8201;weeks' gestation), delivered via C&#8208;section, and between 0 and 3&#8201;months of age at the time of enrollment. Additionally, the parents needed to be residents of the United States with access to US postal services.</p><p>Exclusion criteria included infants who had previously received probiotic supplements, multiple birth infants, and infants with pre&#8208;existing health conditions with the exception of eczema and rashes. Additional details in Appendix&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="pai70182-sec-0011"><label>2.3</label><title>Participant flow</title><p>Participants were randomized to the intervention arm or self&#8208;directed control. The study lasted approximately 6&#8201;months, with microbiome samples collected at time points 1 and 2, and survey data collected at time points 1, 2, and 3. Time point 2 occurred 12&#8211;20&#8201;weeks after time point 1, and time point 3 followed 8&#8211;12&#8201;weeks later (Figure&#160;<xref rid="pai70182-fig-0001" ref-type="fig">1</xref>).</p><fig position="float" fig-type="FIGURE" id="pai70182-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Participant study flow and study design. (A) Progression of participants from recruitment to analysis. (B) Participant flow from enrollment to exit. Participants were randomized into intervention (green) and control (purple) arms. The intervention arm received bi&#8208;weekly educational emails and coaching calls every 4&#8201;weeks (green triangles). Data collection occurred at time point 1 (~2&#8201;weeks post&#8208;randomization) and time point 2 (10&#8211;12&#8201;weeks after time point 1). Exit surveys were completed at time point 3.</p></caption><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="PAI-36-e70182-g004.jpg"/></fig></sec><sec id="pai70182-sec-0012"><label>2.4</label><title>Study outcomes</title><p>The primary outcome was differences in microbiome composition between study arms, measured by alpha and beta diversity, the mean relative abundance of pre&#8208;defined key taxa in the infant gut microbiome&#8212;selected for their known prevalence in early life<xref rid="pai70182-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70182-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>&#8212;and the mean abundance of genes related to HMO degradation and SCFA production, which represent core functions of the early life microbiome (Appendix&#160;<xref rid="pai70182-supitem-0001" ref-type="supplementary-material">S1</xref>).<xref rid="pai70182-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="pai70182-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> The secondary outcome was effects on a birth&#8208;related microbiome signature&#8212;C&#8208;section index&#8212;between arms, which was compared to a reference group of vaginally delivered infants. An additional outcome was differences in the prevalence of symptoms like gastroesophageal reflux and atopic conditions like atopic dermatitis and food allergy, reported by parents, compared between arms.</p></sec><sec id="pai70182-sec-0013"><label>2.5</label><title>Sample collection</title><p>Participants were provided with two microbiome stool sample collection kits, containing a DNA&#8208;free, sterile collection system with an active drying tube (FLOQSwab&#8208;ADT; Copan Diagnostics, USA),<xref rid="pai70182-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> instructions, a biosafety bag, and a prepaid return shipping envelope. Parents were instructed to collect a stool sample from a soiled diaper.</p></sec><sec id="pai70182-sec-0014"><label>2.6</label><title>Wellness program contents</title><p>Participants in the intervention arm were provided access to a gut microbiome&#8208;based, integrative wellness program aimed at supporting infant gut health. Although this program is commercially available through Tiny Health, it was labeled in a way that no link to the company could be identified during recruitment for all participants and throughout the intervention for the control arm. In addition, Tiny Health did not publish anything related to this study, ensuring that participants in the control arm could not identify the company as its sponsor until after the intervention was complete&#8212;when they received their microbiome reports. Detailed methods of the program's content and how these were delivered can be found in Appendix&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="pai70182-sec-0015"><label>2.7</label><title>Sample and data processing</title><p>Samples were received by and processed in a CLIA/CAP&#8208;certified lab, compliant with the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP). Total DNA was extracted using the DNeasy Powersoil Pro kit (Qiagen, Germany). The concentration of extracted DNA at time point 1 ranged from 2.14 to 184&#8201;ng/&#956;L and the bacterial&#8208;to&#8208;host ratio (used as a proxy for bacterial load)<xref rid="pai70182-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> ranged from 0.445 to 0.999. After quality control (QC), libraries were prepared using the Nextera kit. Library fragment sizes were then assessed using Agilent TapeStation or Bioanalyzer and quantified by qPCR. All samples and libraries passed QC and were sequenced to at least 10 million reads on a NextGen Illumina Platform. Additional details in Appendix&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="pai70182-sec-0016"><label>2.8</label><title>Randomization</title><p>To ensure balance across biologically relevant variables, infants were stratified by a combination of sex and age at enrollment (0&#8211;30, 31&#8211;60, and 61&#8211;90&#8201;days), resulting in six strata. Additional details in Appendix&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="pai70182-sec-0017"><label>2.9</label><title>Statistical analyses</title><p>Analyses were conducted on the per&#8208;protocol population, defined as participants who completed the exit survey or provided microbiome samples at both time points 1 and 2. Participant characteristics were compared between arms using Fisher's exact test for categorical variables and Mann&#8211;Whitney <italic toggle="yes">U</italic> test for continuous variables. For Mann&#8211;Whitney <italic toggle="yes">U</italic> tests, we report the change&#8208;in&#8208;location parameter as the estimate, as well as the 95% confidence intervals for this parameter. In addition, we report medians as estimates of central tendency.</p><p>Microbiome diversity metrics were calculated using the vegan package in R.<xref rid="pai70182-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Shannon diversity and Bray&#8208;Curtis distances were used to assess alpha and beta diversity, respectively. To assess compositional differences both between and within arms, we employed pairwise PERMANOVA tests via adonis2. The pairwise tests were accomplished by subsetting the data to each grouping of interest (i.e., intervention&#8208;sample_1 vs. control&#8208;sample_1, intervention&#8208;sample_1 vs. intervention&#8208;sample_2, etc.) and running the adonis2 test for each. For within&#8208;arm comparisons where paired observations exist, restricted permutations were defined with blocks for the individual. Community dispersion was assessed with betadisper, followed by Tukey's HSD for post hoc comparisons. Non&#8208;metric multidimensional scaling (NMDS) visualizations were generated using metaMDS from the vegan package. All <italic toggle="yes">p</italic> values for diversity metrics were adjusted for multiple comparisons using the Benjamini&#8208;Hochberg (BH) method (<italic toggle="yes">q</italic> values, 10 tests).</p><p>Taxa and functional gene abundances were compared within study arms using the Wilcoxon signed&#8208;rank test, and between arms using the Mann&#8211;Whitney <italic toggle="yes">U</italic> test. <italic toggle="yes">p</italic> values were corrected for multiple testing using the BH method (<italic toggle="yes">q</italic> values, 48 tests for taxa and 24 tests for genes).</p><p>Analogous to the approach presented by Stokholm et&#160;al. (2020) and independent of the study data presented here, we developed a taxonomy&#8208;based C&#8208;section index to evaluate the C&#8208;section signature, focusing on taxa that are differentially abundant in infants delivered via C&#8208;section compared to those delivered vaginally (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S1</xref>)<xref rid="pai70182-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> identified using a multivariable association analysis (MaAsLin2).<xref rid="pai70182-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> To do this, we used proprietary data plus data from Stokholm et&#160;al. (2016), Shao et&#160;al. (2019), and Reyman et&#160;al. (2019).<xref rid="pai70182-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="pai70182-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70182-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> The C&#8208;section index was calculated as the sum of C&#8208;section taxa divided by the sum of C&#8208;section and vaginal taxa. C&#8208;section indices were compared between study arms and against external reference groups of vaginally or C&#8208;section delivered infants from Shao et&#160;al. (2019) using the Mann&#8211;Whitney <italic toggle="yes">U</italic> test, with multiple testing correction (BH method, 4 tests).</p><p>We used logistic regression to compare condition prevalence between study arms before and after the intervention. Conditions reported at time points 2 and 3 were aggregated, with a positive report at either time point 2 or 3 classifying a participant as positive for that condition. Potential confounders, such as age and sex, were tested as random effects using a linear mixed model but were not significant and were excluded from further analyses.</p><p>Because AD is a common early&#8208;life condition and often the first step in the atopic march,<xref rid="pai70182-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> we conducted an additional analysis comparing taxa abundance and C&#8208;section index in AD versus non&#8208;AD participants using the Mann&#8211;Whitney <italic toggle="yes">U</italic> test, with multiple testing correction (BH method, 3 tests).</p><p>For all comparisons, a <italic toggle="yes">q</italic> value &lt;0.1 was deemed significant, except for condition prevalence analysis, where a nominal <italic toggle="yes">p</italic> value &lt;0.05 was considered significant.</p><p>Sample size was determined through a power calculation using a <italic toggle="yes">t</italic>&#8208;test to detect a difference in the relative abundance of <italic toggle="yes">Bifidobacterium</italic> with an effect size of 0.8 (Cohen's d), aiming for 80% power at <italic toggle="yes">&#945;</italic>&#8201;=&#8201;.05. This analysis suggested we would need 25 participants per group. However, Mann&#8211;Whitney <italic toggle="yes">U</italic> tests were used instead after we found the data did not satisfy the distributional assumptions of the <italic toggle="yes">t</italic>&#8208;test. Additional methods in Appendix&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>.</p></sec></sec><sec sec-type="results" id="pai70182-sec-0018"><label>3</label><title>RESULTS</title><sec id="pai70182-sec-0019"><label>3.1</label><title>Study recruitment and cohort demographics</title><p>The power analysis determined a minimum sample size of 25 infants per arm. A total of 73 parent&#8208;infant dyads were consented into the study. Eighteen participants did not complete the study: 3 of whom officially withdrew and 15 were lost to follow&#8208;up (Figure&#160;<xref rid="pai70182-fig-0001" ref-type="fig">1A</xref>). One participant from the control arm was excluded due to using an at&#8208;home microbiome test for personal use during the study period. At time point 2, 25 intervention and 29 control participants had completed survey data collection and microbiome sample collection. At time point 3, 18 intervention and 28 control participants completed the exit survey, thereby providing all data points.</p><p>At time point 1, participant characteristics were not different between arms (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>). The percentage of infants receiving a majority of breast milk decreased in both arms but was not different between arms at any time point (time point 1: <italic toggle="yes">p</italic>&#8201;=&#8201;.126, time point 2: <italic toggle="yes">p</italic>&#8201;=&#8201;.576, time point 3: <italic toggle="yes">p</italic>&#8201;=&#8201;.541). All infants were introduced to solids during the study. The proportion of infants consuming more than 10% solids was not different between arms at time point 2 (<italic toggle="yes">p</italic>&#8201;=&#8201;.535) but became different at time point 3 (<italic toggle="yes">p</italic>&#8201;=&#8201;.011), with a higher percentage in controls.</p><p>Since probiotic usage before recruitment was an exclusion criterion, both arms were not different at time point 1 (<italic toggle="yes">p</italic>&#8201;=&#8201;1). During the intervention, a potential recommendation was a <italic toggle="yes">Bifidobacterium</italic> probiotic. By time point 2, usage increased to 64% in the intervention arm while remaining unchanged at 3% in the control arm (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001). At time point 3, usage in the intervention arm was 67%, while the control arm saw a modest increase to 7% (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001) (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>). At time points 2 and 3, use of <italic toggle="yes">Lactobacillus</italic> probiotics was not different between arms.</p><p>No harms or unintended effects were reported by participants during the trial period, and no serious adverse events occurred.</p></sec><sec id="pai70182-sec-0020"><label>3.2</label><title>Microbial composition shifts after the intervention</title><p>We observed a strong shift in microbial community structure in the intervention arm that was not present in the control arm. At the genus level, <italic toggle="yes">Bifidobacterium</italic> was the most prevalent genus in both arms (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2A</xref>). While there were no differences in Shannon diversity index between the two arms at time point 1, we observed a difference at time point 2 (point estimate: 0.891, [95% CI, 0.029&#8211;1.637], <italic toggle="yes">p</italic>&#8201;=&#8201;.042, <italic toggle="yes">q</italic>&#8201;=&#8201;.085), driven by a decrease observed only in the intervention arm (point estimate: &#8722;0.768, [95% CI, &#8722;1.375 to &#8722;0.368], <italic toggle="yes">p</italic>&#8201;=&#8201;.014, <italic toggle="yes">q</italic>&#8201;=&#8201;.057) (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2B</xref>, Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S3</xref>). For beta diversity, we observed a marked shift in gut microbiome composition from time point 1 to time point 2 in the intervention arm only (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2C,D</xref> and Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S1</xref>, PERMANOVA <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">q</italic>&#8201;&lt;&#8201;.001). The shift observed in the intervention arm was consistent between subjects, as indicated by the direction and magnitude of centroid movement (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2D</xref>) and the significant change in MDS1 values (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">q</italic>&#8201;&lt;&#8201;.001) (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2E</xref>). In contrast, subjects in the control arm displayed more subtle and heterogeneous shifts, with the microbiome of these infants moving in divergent directions (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2C</xref>) and with no significant overall change (Figure&#160;<xref rid="pai70182-fig-0002" ref-type="fig">2E</xref>). These observed differences in microbiome composition indicate a unifying compositional shift in the intervention arm that was absent in the control arm.</p><fig position="float" fig-type="FIGURE" id="pai70182-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Changes in microbial community structure and alpha and beta diversity post&#8208;intervention. (A) Relative abundance of the 20 most abundant microbial taxa at the genus level. Less abundant taxa were grouped and are shown as &#8220;Other&#8221;. Each vertical bar represents an individual sample, and sample order is consistent across top and bottom panels to allow for individual&#8208;level comparisons. (B) Shannon diversity index for control and intervention arms. (C, D) Non&#8208;metric multidimensional scaling (NMDS) plots based on Bray&#8208;Curtis distances, illustrating the clustering of microbial communities for each sample in (C) control and (D) intervention arm. Ellipses represent the standard error around group centroids for each time point, and the black arrows connect group centroids between time point 1 and time point 2 with the arrowhead pointing to time point 2. Samples from the same individual are joined by gray arrows with the arrowhead pointing to time point 2. (E) Boxplots of MDS1 from a NMDS analysis based on Bray&#8208;Curtis dissimilarities. Boxplots show the median, interquartile range, and individual data points for each arm and time point. Points from the same individual are connected by lines to illustrate within&#8208;subject changes over time. The Wilcoxon signed&#8208;rank test was used to assess statistical significance between time points, and the Mann&#8211;Whitney <italic toggle="yes">U</italic> test and PERMANOVA were used to assess statistical significance between arms. <italic toggle="yes">p</italic> values were adjusted for multiple comparisons using the BH method (<italic toggle="yes">q</italic> values, 10 tests). *<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.1, ***<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.01; n.s., not significant.</p></caption><graphic position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="PAI-36-e70182-g005.jpg"/></fig></sec><sec id="pai70182-sec-0021"><label>3.3</label><title>Changes in key bacterial taxa in the intervention arm</title><p>Next, we compared the relative abundance of key infant taxa across arms and samples (Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S4</xref>). Between time points, there was an increase in <italic toggle="yes">Bifidobacterium</italic> both for the intervention (medians: time point 1&#8201;=&#8201;31%, time point 2&#8201;=&#8201;82%, estimate&#8201;=&#8201;36%, [95% CI, 15%&#8211;53%], <italic toggle="yes">p</italic>&#8201;=&#8201;.001, <italic toggle="yes">q</italic>&#8201;=&#8201;.007) and the control arm (medians: time point 1&#8201;=&#8201;45%, time point 2&#8201;=&#8201;55%, estimate&#8201;=&#8201;8.1%, [95% CI, 2%&#8211;22%], <italic toggle="yes">p</italic>&#8201;=&#8201;.014, <italic toggle="yes">q</italic>&#8201;=&#8201;.084) (Figure&#160;<xref rid="pai70182-fig-0003" ref-type="fig">3A</xref>), but the intervention arm reached higher levels than the control arm (estimate&#8201;=&#8201;&#8722;18%, [95% CI, &#8722;37% to &#8722;12%] <italic toggle="yes">p</italic>&#8201;=&#8201;.025, <italic toggle="yes">q</italic>&#8201;=&#8201;.121) (Figure&#160;<xref rid="pai70182-fig-0003" ref-type="fig">3A</xref>). For infant&#8208;associated <italic toggle="yes">Bifidobacterium</italic> species, that is, species that have the genetic capacity to degrade HMOs from breast milk&#8212;namely <italic toggle="yes">B. infantis</italic>, <italic toggle="yes">B. longum</italic>, <italic toggle="yes">B. breve</italic>, and <italic toggle="yes">B. bifidum</italic>, <italic toggle="yes">B. infantis</italic> increased in the intervention arm (medians: time point 1&#8201;=&#8201;.4%, time point 2&#8201;=&#8201;61%, estimate&#8201;=&#8201;41%, [95% CI, 29%&#8211;59%], <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">q</italic>&#8201;=&#8201;.001) and was more abundant than in the control arm at time point 2 (medians: Intervention&#8201;=&#8201;61%, Control&#8201;=&#8201;3.4%, estimate&#8201;=&#8201;&#8722;27%, [95% CI, &#8722;61% to &#8722;6%], <italic toggle="yes">p</italic>&#8201;=&#8201;.001, <italic toggle="yes">q</italic>&#8201;=&#8201;.013) (Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>). The levels of the other infant&#8208;associated <italic toggle="yes">Bifidobacterium</italic> species were not different between arms at time points 1 and 2 (Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S2</xref>).</p><fig position="float" fig-type="FIGURE" id="pai70182-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Key taxa and HMO&#8208;degrading gene abundances change over time and between control and intervention arm. Relative abundance of (A) <italic toggle="yes">Bifidobacterium</italic> and (B) <italic toggle="yes">Enterobacteriaceae</italic>; and gene abundance (measured in RPKM) of (C) &#945;&#8208;L&#8208;fucosidase and (D) 2,3&#8208;2,6&#8208;a&#8208;sialidase. Boxplots show the median, interquartile range, and individual data points for each arm and time point. The Wilcoxon signed&#8208;rank test was used to assess statistical significance between time points, and the Mann&#8211;Whitney <italic toggle="yes">U</italic> test was used to assess statistical significance between arms. <italic toggle="yes">p</italic> values were adjusted for multiple comparisons using the BH method (<italic toggle="yes">q</italic> values, 48 tests for taxa and 24 tests for genes). *<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.1, **<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.05, ***<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.01, n.s., not significant.</p></caption><graphic position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="PAI-36-e70182-g003.jpg"/></fig><p>We next inspected the relative abundance of opportunistic pathogens commonly found at high levels in the gut microbiome of infants born by C&#8208;section (Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S4</xref>). The relative abundance of <italic toggle="yes">Enterobacteriaceae</italic> decreased from time point 1 to time point 2 in both the control (medians: time point 1&#8201;=&#8201;15.9%, time point 2&#8201;=&#8201;3.1%, estimate&#8201;=&#8201;&#8722;10%, [95% CI, &#8722;16% to &#8722;5%], <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">q</italic>&#8201;=&#8201;.002) and intervention arm (time point 1&#8201;=&#8201;16.3%, time point 2&#8201;=&#8201;3.7%, estimate&#8201;=&#8201;&#8722;20%, [95% CI, &#8722;30% to &#8722;8%], <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">q</italic>&#8201;=&#8201;.001) (Figure&#160;<xref rid="pai70182-fig-0003" ref-type="fig">3B</xref>). For <italic toggle="yes">Escherichia coli</italic>, a decrease between time point 1 and time point 2 was observed only in the intervention arm (medians: time point 1&#8201;=&#8201;5.5%, time point 2&#8201;=&#8201;1.4%, estimate&#8201;=&#8201;&#8722;4.5%, [95% CI, &#8722;15% to &#8722;1%], <italic toggle="yes">p</italic>&#8201;=&#8201;.009, <italic toggle="yes">q</italic>&#8201;=&#8201;.059) (Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S3</xref>). At any time point, no differences between arms were observed for these or the other analyzed opportunistic pathogens (Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S3</xref>).</p></sec><sec id="pai70182-sec-0022"><label>3.4</label><title>The intervention led to functional shifts in <styled-content style="fixed-case" toggle="no">HMO</styled-content> degradation and <styled-content style="fixed-case" toggle="no">SCFA</styled-content> production genes</title><p>We assessed the abundance of microbial genes associated with HMO degradation (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S5</xref>) and SCFA production (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S6</xref>). At time point 2, the intervention arm showed a higher abundance of HMO degradation genes compared to the control arm (Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S7</xref>). This included genes for &#945;&#8208;L&#8208;fucosidase (medians: Intervention&#8201;=&#8201;3157, Control&#8201;=&#8201;1638, estimate&#8201;=&#8201;&#8722;1041, [95% CI, &#8722;2056 to &#8722;163], <italic toggle="yes">p</italic>&#8201;=&#8201;.019, <italic toggle="yes">q</italic>&#8201;=&#8201;.046) (Figure&#160;<xref rid="pai70182-fig-0003" ref-type="fig">3C</xref>), 2,3&#8208;2,6&#8208;a&#8208;sialidase (medians: Intervention&#8201;=&#8201;3157, Control&#8201;=&#8201;1638, estimate&#8201;=&#8201;&#8722;778, [95% CI, &#8722;1273 to &#8722;136], <italic toggle="yes">p</italic>&#8201;=&#8201;.012, <italic toggle="yes">q</italic>&#8201;=&#8201;.033) (Figure&#160;<xref rid="pai70182-fig-0003" ref-type="fig">3D</xref>), and other HMO&#8208;degrading enzymes (medians: Intervention&#8201;=&#8201;4132, Control&#8201;=&#8201;2789, estimate&#8201;=&#8201;&#8722;1204, [95% CI, &#8722;2011 to &#8722;469], <italic toggle="yes">p</italic>&#8201;=&#8201;.002, <italic toggle="yes">q</italic>&#8201;=&#8201;.012) (Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S3F</xref>). The abundance of butyrate&#8208;related genes decreased from time point 1 to time point 2 only in the intervention arm (medians: time point 1&#8201;=&#8201;428, time point 2&#8201;=&#8201;98, estimate&#8201;=&#8201;&#8722;224, [95% CI, &#8722;379 to &#8722;90], <italic toggle="yes">p</italic>&#8201;=&#8201;.002, <italic toggle="yes">q</italic>&#8201;=&#8201;.012), and it was lower in the intervention arm than in the control arm at time point 2 (medians: Intervention&#8201;=&#8201;98, Control&#8201;=&#8201;378, estimate&#8201;=&#8201;123, [95% CI, 1.2 to 338], <italic toggle="yes">p</italic>&#8201;=&#8201;.046, <italic toggle="yes">q</italic>&#8201;=&#8201;.091) (Figure&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S4B</xref>). No differences between arms were observed for the other SCFA genes (Figure&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S4A,C</xref> and Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S7</xref>).</p></sec><sec id="pai70182-sec-0023"><label>3.5</label><title>The intervention reduced C&#8208;section index to levels comparable to those of vaginally&#8208;born infants</title><p>We then assessed the intervention's impact on C&#8208;section index, a metric that represents the ratio of taxa associated with C&#8208;section births to those associated with vaginal births (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S1</xref>). Higher index values reflect a microbiome profile typical of C&#8208;section&#8208;delivered infants.</p><p>The C&#8208;section index went down in the intervention arm between time points 1 and 2, a change not observed in the control arm (Figure&#160;<xref rid="pai70182-fig-0004" ref-type="fig">4A&#8211;C</xref>). Comparing the C&#8208;section index of both arms to infants from Shao et&#160;al. (2019), we found that at time point 1, both arms had higher C&#8208;section indices than vaginally&#8208;born infants (control: <italic toggle="yes">p</italic>&#8201;=&#8201;.005, <italic toggle="yes">q</italic>&#8201;=&#8201;.007; intervention: <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">q</italic>&#8201;&lt;&#8201;.001). By time point 2, only the control arm remained different (<italic toggle="yes">p</italic>&#8201;=&#8201;.013, <italic toggle="yes">q</italic>&#8201;=&#8201;.052) (Figure&#160;<xref rid="pai70182-fig-0004" ref-type="fig">4C</xref>, Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S8</xref>), suggesting the intervention shifted the microbiome of C&#8208;section infants closer to that of vaginally&#8208;born infants.</p><fig position="float" fig-type="FIGURE" id="pai70182-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Reduced C&#8208;section index in the intervention arm. (A, B) Non&#8208;metric multidimensional scaling (NMDS) plots based on Bray&#8208;Curtis distances shaded by C&#8208;section index. Plots show the clustering of microbial communities for time point 1 (circles) and time point 2 (triangles) in (A) the control arm and (B) the intervention arm. Ellipses represent standard error around the group centroids for each time point. (C) C&#8208;section index across time points 1 and 2 in the control and intervention arms, shown alongside a group of C&#8208;section&#8208;delivered and vaginally&#8208;delivered infants from Shao et&#160;al. (2019): Time point 1 at 21&#8201;days, time point 2 between 100 and 365&#8201;days. The Wilcoxon signed&#8208;rank test was used to assess statistical significance between time points, and the Mann&#8211;Whitney <italic toggle="yes">U</italic> test was used to assess statistical significance between arms. <italic toggle="yes">p</italic> values were adjusted for multiple comparisons using the BH method (<italic toggle="yes">q</italic> values, 4 tests). *<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.1, ***<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.01, n.s., not significant.</p></caption><graphic position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="PAI-36-e70182-g002.jpg"/></fig></sec><sec id="pai70182-sec-0024"><label>3.6</label><title>Reduced prevalence of health conditions in the intervention arm</title><p>Next, we assessed the intervention's effects on the prevalence of conditions before and after the intervention. At time point 1, reflux was the most reported condition, followed by atopy (i.e., infants with AD, food allergies, cow's milk protein allergy, or sensitivities through breast milk) (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S9</xref>). No differences in any reported conditions were observed between arms at time point 1 (Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S10</xref>). Considering both time points 2 and 3, the intervention arm contained fewer infants with reported conditions overall (<italic toggle="yes">p</italic>&#8201;=&#8201;.004), as well as fewer cases of atopy (<italic toggle="yes">p</italic>&#8201;=&#8201;.034) and AD (<italic toggle="yes">p</italic>&#8201;=&#8201;.031) (Figure&#160;<xref rid="pai70182-fig-0005" ref-type="fig">5A</xref>, Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S9</xref> and Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S11</xref>). Together, this suggests the intervention contributed to reducing the prevalence of atopic conditions, despite its short duration and relatively small size.</p><fig position="float" fig-type="FIGURE" id="pai70182-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Infants with atopic dermatitis have a higher C&#8208;section index and altered gut microbiome composition. (A) Percentage of infants with different health conditions across time points. The left panel shows the percentage of infants with any condition, and the central panel shows the percentage of infants with atopic dermatitis (AD) and/or any food reaction. (B&#8211;D) Association between AD status at time point 2 and (B) C&#8208;section index, relative abundance of (C) <italic toggle="yes">Bifidobacterium</italic> and (D) <italic toggle="yes">Enterobacteriaceae</italic>. The Mann&#8211;Whitney <italic toggle="yes">U</italic> test was used to assess statistical significance between the AD and non&#8208;AD groups. <italic toggle="yes">p</italic> values were adjusted for multiple comparisons using the BH method (<italic toggle="yes">q</italic> values, 3 tests). *<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.1, **<italic toggle="yes">q</italic>&#8201;&lt;&#8201;.05.</p></caption><graphic position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="PAI-36-e70182-g001.jpg"/></fig></sec><sec id="pai70182-sec-0025"><label>3.7</label><title>Infants with atopic dermatitis have an elevated C&#8208;section index and altered levels of key bacterial taxa</title><p>We further examined differences among infants with and without AD independent of the study arm. When participants were stratified according to their AD status, there were no demographic or baseline differences between the groups (Table&#160;<xref rid="pai70182-supitem-0002" ref-type="supplementary-material">S12</xref>). At time point 2, infants with AD had a higher C&#8208;section index compared to those without AD (point estimate, 0.130, [95% CI, 0.027 to 0.550], <italic toggle="yes">p</italic>&#8201;=&#8201;.006; <italic toggle="yes">q</italic>&#8201;=&#8201;.019) (Figure&#160;<xref rid="pai70182-fig-0005" ref-type="fig">5B</xref> and Table&#160;<xref rid="pai70182-supitem-0003" ref-type="supplementary-material">S13</xref>). <italic toggle="yes">Bifidobacterium</italic> levels were higher (point estimate, &#8722;0.233, [95% CI, &#8722;0.668 to 0.000], <italic toggle="yes">p</italic>&#8201;=&#8201;.056; <italic toggle="yes">q</italic>&#8201;=&#8201;.058) (Figure&#160;<xref rid="pai70182-fig-0005" ref-type="fig">5C</xref>) and <italic toggle="yes">Enterobacteriaceae</italic> levels were lower (point estimate, 0.030, [CI, &#8722;0.002 to 0.088], <italic toggle="yes">p</italic>&#8201;=&#8201;.058; <italic toggle="yes">q</italic>&#8201;=&#8201;.058) in infants without AD (Figure&#160;<xref rid="pai70182-fig-0005" ref-type="fig">5D</xref>). These findings suggest a link between a C&#8208;section&#8208;like microbiome and the presence of AD.</p></sec></sec><sec sec-type="discussion" id="pai70182-sec-0026"><label>4</label><title>DISCUSSION</title><p>Infants born via C&#8208;section often exhibit distinct gut microbiome composition, are at higher risk of developing atopic conditions, and have elevated risk of chronic inflammatory conditions later in life. This study explored whether an integrated approach of gut microbiome&#8208;focused education, coaching, and reports with tailored recommendations could improve infant gut health and potentially mitigate these risks. We found that our intervention led to significant changes in the gut microbiome, with notable shifts in both microbial taxonomy and functions, that made the gut microbiome profile more similar to that of vaginally born&#8208;infants. The intervention also resulted in fewer reports of atopic conditions. Together, these results suggest that targeted microbiome interventions can be effective and may lower the risk of future health conditions in C&#8208;section&#8208;born infants.</p><p>Breastfeeding is a powerful determinant of gut microbiome composition,<xref rid="pai70182-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70182-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> playing a critical role in correcting imbalances caused by C&#8208;section delivery or antibiotic use.<xref rid="pai70182-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> In this study, most infants were exclusively breastfed, and those who were mixed&#8208;fed still primarily received breast milk. This potentially explains the increase in <italic toggle="yes">Bifidobacterium</italic> observed in both arms and the reduction of <italic toggle="yes">Enterobacteriaceae</italic>, which has been previously observed as part of normal gut maturation in the context of predominant breastfeeding.<xref rid="pai70182-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Larger studies may help to better understand these interactions and optimize interventions to better align with various feeding practices.</p><p>Not all breastfed infants may be able to fully benefit from breast milk, as effective HMO degradation depends on the presence of specific <italic toggle="yes">Bifidobacterium</italic> species.<xref rid="pai70182-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> In this context, the increase in <italic toggle="yes">B. infantis</italic> and lower alpha diversity<xref rid="pai70182-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> observed in the intervention arm stands out, as <italic toggle="yes">B. infantis</italic> is able to comprehensively degrade HMOs from breast milk<xref rid="pai70182-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> leading to domination of the community.<xref rid="pai70182-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> This is also reflected in the increased abundance of HMO degradation genes in the gut microbiome of the intervention arm. We interpret these changes as a favorable turn towards a more specialized microbial community. The presence of expert HMO&#8208;degraders suggests utilization of HMOs, which results in the production of beneficial metabolites that mature the immune system<xref rid="pai70182-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> and contribute to colonization resistance.<xref rid="pai70182-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="pai70182-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="pai70182-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> The increase in <italic toggle="yes">B. infantis</italic> is in part attributable to probiotics: infants in the intervention arm with less than 80% relative abundance of <italic toggle="yes">Bifidobacterium</italic> were recommended several choices of probiotics containing clinically validated infant&#8208;type <italic toggle="yes">Bifidobacterium</italic> strains. Based on survey data, 64% of infants in the intervention arm took a <italic toggle="yes">Bifidobacterium</italic> probiotic between time point 1 and time point 2, compared to only 3% in the control arm, where no recommendations were provided.</p><p>We also observed a significant decrease in genes associated with butyrate production at time point 2, but only within the intervention arm. While this may initially appear counterintuitive, we believe this reduction brought butyrate gene abundance into a range that likely reflects the normal developmental stage of the infant gut microbiome at this early age, when breast milk (or formula) is still the primary source of nutrition. Butyrate&#8208;producing bacteria that specialize in metabolizing complex starches and fibers present in solid foods&#8212;such as <italic toggle="yes">Bacteroides</italic>, <italic toggle="yes">Faecalibacterium prausnitzii</italic>, <italic toggle="yes">Blautia</italic>, and <italic toggle="yes">Roseburia</italic>&#8212;tend to markedly increase with the cessation of breastfeeding.<xref rid="pai70182-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="pai70182-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Thus, a low abundance of butyrate&#8208;producing genes at this stage is expected and may reflect a more age&#8208;appropriate maturation of the microbial community, as accelerated maturation has been linked to increased risk of asthma<xref rid="pai70182-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="pai70182-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> and AD.<xref rid="pai70182-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>
</p><p>In terms of health outcomes, the intervention arm reported significantly fewer cases of atopy and AD, suggesting that the intervention translated into tangible health benefits even within the short follow&#8208;up period. The intervention also successfully reduced the C&#8208;section index, bringing the gut microbiome profiles of C&#8208;section&#8208;delivered infants closer to those of vaginally&#8208;born infants. In contrast, the C&#8208;section index in the control arm remained significantly elevated at time point 2. When grouped according to their AD status across arms, infants with AD also had a markedly higher C&#8208;section index. Our findings differ from those of Shao et&#160;al. (2019), who reported no significant difference in the C&#8208;section index between C&#8208;section and vaginally&#8208;delivered infants at a similar age. Such discrepancies may stem from differences in sampling and bioinformatics processes, feeding practices, and geography between the studies. To control for technical variation stemming from bioinformatics pipelines, we reprocessed all raw reads using the same bioinformatics pipeline. Regarding feeding practices, our cohort had a higher proportion of exclusively breastfed infants, though breastfeeding rates were balanced across study arms. Participants in the comparison study were recruited in the UK, while our study spanned multiple U.S. locations, and differences in lifestyle as well as environmental exposures (including bacteria in the environment) are expected.</p><p>While this study presents promising results, we acknowledge its limitations. First, the relatively small sample size may limit the generalizability of the findings. Additionally, the short follow&#8208;up period may not capture the long&#8208;term effects of the intervention on the gut microbiome and health outcomes. We did not collect stool samples at time point 3, where some of the differences in health conditions were observed. To reduce concerns about potential bias introduced by attrition at time point 3, we compared baseline characteristics of participants who completed the study between the two arms and found no significant differences in demographics or clinical factors. Finally, most infants in our study were exclusively breastfed, limiting our ability to evaluate the intervention's impact on formula&#8208;fed infants.</p><p>Future studies should have longer follow&#8208;up, including medical diagnosis of health conditions, and enroll formula&#8208;fed infants. In addition, this study was not prescriptive, as it allowed parents to make their own choices regarding recommendations and product brand selection. While this enhances real&#8208;world applicability, it also introduces variability. Despite these limitations, we view the levels of statistical significance of the presented findings in this small human cohort as remarkable and highly encouraging for the field.</p><p>In conclusion, this study provides evidence that a personalized microbiome intervention can significantly influence the gut microbiome composition and functionality of C&#8208;section&#8208;born infants. This approach is different from previous interventions that mainly focused on the effects of probiotics on gut microbiome composition or specific health conditions.<xref rid="pai70182-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>, <xref rid="pai70182-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="pai70182-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> Our approach is the first to leverage a comprehensive microbiome intervention with a variety of actions and personal coaching. Whether similar results can be obtained without coaching and simplified interventions is a topic of future study. The significant alterations in microbiome composition and functionality as well as reduction in atopic conditions observed within the short time frame of this study highlight the potential of our intervention strategy to potentially prevent chronic health conditions.</p></sec><sec id="pai70182-sec-0033"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Pamela A. Nieto:</bold> Writing &#8211; original draft; writing &#8211; review and editing; visualization. <bold>Claudia Nakama:</bold> Investigation; project administration; visualization; writing &#8211; original draft; writing &#8211; review and editing. <bold>Julian Trachsel:</bold> Formal analysis; methodology; visualization; writing &#8211; review and editing. <bold>David Goad:</bold> Data curation; methodology; software. <bold>Taylor K. Soderborg:</bold> Investigation; writing &#8211; review and editing. <bold>Danielle Shea Tan:</bold> Investigation; writing &#8211; review and editing. <bold>Amy Orlandi:</bold> Investigation; writing &#8211; review and editing. <bold>Qian Yuan:</bold> Writing &#8211; review and editing. <bold>Elisa Song:</bold> Writing &#8211; review and editing. <bold>Noel T. Mueller:</bold> Writing &#8211; review and editing. <bold>Ruben A. Mars:</bold> Conceptualization; formal analysis; writing &#8211; review and editing. <bold>Cheryl Sew Hoy:</bold> Conceptualization; supervision; writing &#8211; review and editing; funding acquisition. <bold>Kimberley V. Sukhum:</bold> Conceptualization; investigation; formal analysis; methodology; supervision; visualization; writing &#8211; review and editing.</p></sec><sec id="pai70182-sec-0028"><title>FUNDING INFORMATION</title><p>This study was financed and sponsored by Seeding, Inc. doing business as Tiny Health.</p></sec><sec sec-type="COI-statement" id="pai70182-sec-0029"><title>CONFLICT OF INTEREST STATEMENT</title><p>P.A.N., C.N., J.T., D.G., T.S., D.S.T., A.O., and K.V.S. are employees of Tiny Health, and except for A.O., all hold stock options in the company. K.V.S. and T.S. have been paid by Tiny Health to attend meetings. K.V.S. and D.G. have planned and pending patents related to the research. E.S. serves as the Chief Medical Officer (CMO) of Tiny Health. N.T.M. is a scientific advisor to Tiny Health. R.A.M. is a founding advisor to Tiny Health, a role approved by the Medical&#8208;Industry Relations Committee of Mayo Clinic, fully independent of his employment at Mayo Clinic. C.S.H. is the CEO and founder of Tiny Health. Q.Y. declares no competing interests.</p></sec><sec id="pai70182-sec-0032"><title>ETHICS STATEMENT</title><p>This trial was reviewed and approved by Sterling Institutional Review Board (ID:10947). All participants provided written informed consent before participating in the study. The study was carried out in accordance with the principles of the Declaration of Helsinki. The trial was registered at <ext-link xlink:href="http://clinicaltrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link>, number <ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT06424691">NCT06424691</ext-link>.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pai70182-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Appendix S1.
</p></caption><media xlink:href="PAI-36-e70182-s001.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pai70182-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
Appendix S2.
</p></caption><media xlink:href="PAI-36-e70182-s002.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pai70182-supitem-0003" position="float" content-type="local-data" orientation="portrait"><caption><p>
Appendix S3.
</p></caption><media xlink:href="PAI-36-e70182-s004.xlsx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pai70182-supitem-0004" position="float" content-type="local-data" orientation="portrait"><caption><p>
Appendix S4.
</p></caption><media xlink:href="PAI-36-e70182-s005.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pai70182-supitem-0005" position="float" content-type="local-data" orientation="portrait"><caption><p>
Appendix S5.
</p></caption><media xlink:href="PAI-36-e70182-s003.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="pai70182-sec-0027"><title>ACKNOWLEDGMENTS</title><p>We thank all parents and infants who participated in this study.</p></ack><sec sec-type="data-availability" id="pai70182-sec-0031"><title>DATA AVAILABILITY STATEMENT</title><p>Deidentified individual participant data and microbial reads generated and analyzed during this trial are available in the National Center for Biotechnology Information (NCBI) repository under bioproject accession PRJNA1206145.</p></sec><ref-list content-type="cited-references" id="pai70182-bibl-0001"><title>REFERENCES</title><ref id="pai70182-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="pai70182-cit-0001"><string-name name-style="western"><surname>Nunez</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Nieto</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Mars</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Ghavami</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sew Hoy</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sukhum</surname><given-names>K</given-names></string-name>. <article-title>Early life gut microbiome and its impact on childhood health and chronic conditions</article-title>. <source>Gut Microbes</source>. <year>2025</year>;<volume>17</volume>(<issue>1</issue>):<elocation-id>2463567</elocation-id>.<pub-id pub-id-type="pmid">39916516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/19490976.2025.2463567</pub-id><pub-id pub-id-type="pmcid">PMC11810090</pub-id></mixed-citation></ref><ref id="pai70182-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="pai70182-cit-0002"><string-name name-style="western"><surname>Jakobsson</surname><given-names>HE</given-names></string-name>, <string-name name-style="western"><surname>Abrahamsson</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Jenmalm</surname><given-names>MC</given-names></string-name>, et&#160;al. <article-title>Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section</article-title>. <source>Gut</source>. <year>2014</year>;<volume>63</volume>(<issue>4</issue>):<fpage>559</fpage>&#8208;<lpage>566</lpage>.<pub-id pub-id-type="pmid">23926244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2012-303249</pub-id></mixed-citation></ref><ref id="pai70182-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="pai70182-cit-0003"><string-name name-style="western"><surname>Fujimura</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Sitarik</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Havstad</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation</article-title>. <source>Nat Med</source>. <year>2016</year>;<volume>22</volume>(<issue>10</issue>):<fpage>1187</fpage>&#8208;<lpage>1191</lpage>.<pub-id pub-id-type="pmid">27618652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nm.4176</pub-id><pub-id pub-id-type="pmcid">PMC5053876</pub-id></mixed-citation></ref><ref id="pai70182-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="pai70182-cit-0004"><string-name name-style="western"><surname>Vatanen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Franzosa</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Schwager</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>The human gut microbiome in early&#8208;onset type 1 diabetes from the TEDDY study</article-title>. <source>Nature</source>. <year>2018</year>;<volume>562</volume>(<issue>7728</issue>):<fpage>589</fpage>&#8208;<lpage>594</lpage>.<pub-id pub-id-type="pmid">30356183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-018-0620-2</pub-id><pub-id pub-id-type="pmcid">PMC6296767</pub-id></mixed-citation></ref><ref id="pai70182-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="pai70182-cit-0005"><string-name name-style="western"><surname>Shao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Forster</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Tsaliki</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Stunted microbiota and opportunistic pathogen colonization in caesarean&#8208;section birth</article-title>. <source>Nature</source>. <year>2019</year>;<volume>574</volume>(<issue>7776</issue>):<fpage>117</fpage>&#8208;<lpage>121</lpage>.<pub-id pub-id-type="pmid">31534227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-019-1560-1</pub-id><pub-id pub-id-type="pmcid">PMC6894937</pub-id></mixed-citation></ref><ref id="pai70182-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="pai70182-cit-0006"><string-name name-style="western"><surname>Roswall</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Olsson</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Kovatcheva&#8208;Datchary</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Developmental trajectory of the healthy human gut microbiota during the first 5&#8201;years of life</article-title>. <source>Cell Host Microbe</source>. <year>2021</year>;<volume>29</volume>(<issue>5</issue>):<fpage>765</fpage>&#8208;<lpage>776.e3</lpage>.<pub-id pub-id-type="pmid">33794185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2021.02.021</pub-id></mixed-citation></ref><ref id="pai70182-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="pai70182-cit-0007"><string-name name-style="western"><surname>Dominguez&#8208;Bello</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Costello</surname><given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Contreras</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2010</year>;<volume>107</volume>(<issue>26</issue>):<fpage>11971</fpage>&#8208;<lpage>11975</lpage>.<pub-id pub-id-type="pmid">20566857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1002601107</pub-id><pub-id pub-id-type="pmcid">PMC2900693</pub-id></mixed-citation></ref><ref id="pai70182-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="pai70182-cit-0008"><string-name name-style="western"><surname>Kiely</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Busca</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lane</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hickey</surname><given-names>RM</given-names></string-name>. <article-title>Molecular strategies for the utilisation of human milk oligosaccharides by infant gut&#8208;associated bacteria</article-title>. <source>FEMS Microbiol Rev</source>. <year>2023</year>;<volume>47</volume>(<issue>6</issue>):<elocation-id>fuad056</elocation-id>. doi:<pub-id pub-id-type="doi">10.1093/femsre/fuad056</pub-id><pub-id pub-id-type="pmid">37793834</pub-id><pub-id pub-id-type="pmcid">PMC10629584</pub-id></mixed-citation></ref><ref id="pai70182-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="pai70182-cit-0009"><string-name name-style="western"><surname>Kijner</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cher</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yassour</surname><given-names>M</given-names></string-name>. <article-title>The infant gut commensal Bacteroides dorei presents a generalized transcriptional response to various human milk oligosaccharides</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>854122</elocation-id>.<pub-id pub-id-type="pmid">35372092</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2022.854122</pub-id><pub-id pub-id-type="pmcid">PMC8971754</pub-id></mixed-citation></ref><ref id="pai70182-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="pai70182-cit-0010"><string-name name-style="western"><surname>Hill</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Lynch</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>Murphy</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Evolution of gut microbiota composition from birth to 24&#8201;weeks in the INFANTMET cohort</article-title>. <source>Microbiome</source>. <year>2017</year>;<volume>5</volume>(<issue>1</issue>):<elocation-id>4</elocation-id>.<pub-id pub-id-type="pmid">28095889</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40168-016-0213-y</pub-id><pub-id pub-id-type="pmcid">PMC5240274</pub-id></mixed-citation></ref><ref id="pai70182-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="pai70182-cit-0011"><string-name name-style="western"><surname>Fouhy</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Watkins</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>CJ</given-names></string-name>, et&#160;al. <article-title>Perinatal factors affect the gut microbiota up to four years after birth</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1517</fpage>.<pub-id pub-id-type="pmid">30944304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-09252-4</pub-id><pub-id pub-id-type="pmcid">PMC6447568</pub-id></mixed-citation></ref><ref id="pai70182-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="pai70182-cit-0012"><string-name name-style="western"><surname>Algert</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>McElduff</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>CL</given-names></string-name>. <article-title>Perinatal risk factors for early onset of type 1 diabetes in a 2000&#8208;2005 birth cohort: 2000&#8208;2005 birth cohort and onset of diabetes</article-title>. <source>Diabet Med</source>. <year>2009</year>;<volume>26</volume>(<issue>12</issue>):<fpage>1193</fpage>&#8208;<lpage>1197</lpage>.<pub-id pub-id-type="pmid">20002469</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1464-5491.2009.02878.x</pub-id><pub-id pub-id-type="pmcid">PMC2810440</pub-id></mixed-citation></ref><ref id="pai70182-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="pai70182-cit-0013"><string-name name-style="western"><surname>Huh</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Rifas&#8208;Shiman</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Zera</surname><given-names>CA</given-names></string-name>, et&#160;al. <article-title>Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study</article-title>. <source>Arch Dis Child</source>. <year>2012</year>;<volume>97</volume>(<issue>7</issue>):<fpage>610</fpage>&#8208;<lpage>616</lpage>.<pub-id pub-id-type="pmid">22623615</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/archdischild-2011-301141</pub-id><pub-id pub-id-type="pmcid">PMC3784307</pub-id></mixed-citation></ref><ref id="pai70182-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="pai70182-cit-0014"><string-name name-style="western"><surname>Blustein</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Attina</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Association of caesarean delivery with child adiposity from age 6&#8201;weeks to 15&#8201;years</article-title>. <source>Int J Obes</source>. <year>2013</year>;<volume>37</volume>(<issue>7</issue>):<fpage>900</fpage>&#8208;<lpage>906</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ijo.2013.49</pub-id><pub-id pub-id-type="pmcid">PMC5007946</pub-id><pub-id pub-id-type="pmid">23670220</pub-id></mixed-citation></ref><ref id="pai70182-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="pai70182-cit-0015"><string-name name-style="western"><surname>Stokholm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Thorsen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chawes</surname><given-names>BL</given-names></string-name>, et&#160;al. <article-title>Cesarean section changes neonatal gut colonization</article-title>. <source>J Allergy Clin Immunol</source>. <year>2016</year>;<volume>138</volume>(<issue>3</issue>):<fpage>881</fpage>&#8208;<lpage>889.e2</lpage>.<pub-id pub-id-type="pmid">27045582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2016.01.028</pub-id></mixed-citation></ref><ref id="pai70182-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="pai70182-cit-0016"><string-name name-style="western"><surname>Arrieta</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Stiemsma</surname><given-names>LT</given-names></string-name>, <string-name name-style="western"><surname>Dimitriu</surname><given-names>PA</given-names></string-name>, et&#160;al. <article-title>Early infancy microbial and metabolic alterations affect risk of childhood asthma</article-title>. <source>Sci Transl Med</source>. <year>2015</year>;<volume>7</volume>(<issue>307</issue>):<elocation-id>307ra152</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aab2271</pub-id><pub-id pub-id-type="pmid">26424567</pub-id></mixed-citation></ref><ref id="pai70182-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="pai70182-cit-0017"><string-name name-style="western"><surname>Hill</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Spergel</surname><given-names>JM</given-names></string-name>. <article-title>The atopic march: critical evidence and clinical relevance</article-title>. <source>Ann Allergy Asthma Immunol</source>. <year>2018</year>;<volume>120</volume>(<issue>2</issue>):<fpage>131</fpage>&#8208;<lpage>137</lpage>.<pub-id pub-id-type="pmid">29413336</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.anai.2017.10.037</pub-id><pub-id pub-id-type="pmcid">PMC5806141</pub-id></mixed-citation></ref><ref id="pai70182-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="pai70182-cit-0018"><string-name name-style="western"><surname>Stokholm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Thorsen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Blaser</surname><given-names>MJ</given-names></string-name>, et&#160;al. <article-title>Delivery mode and gut microbial changes correlate with an increased risk of childhood asthma</article-title>. <source>Sci Transl Med</source>. <year>2020</year>;<volume>12</volume>(<issue>569</issue>):<elocation-id>eaax9929</elocation-id>.<pub-id pub-id-type="pmid">33177184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aax9929</pub-id></mixed-citation></ref><ref id="pai70182-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="pai70182-cit-0019"><string-name name-style="western"><surname>Stewart</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Ajami</surname><given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>O'Brien</surname><given-names>JL</given-names></string-name>, et&#160;al. <article-title>Temporal development of the gut microbiome in early childhood from the TEDDY study</article-title>. <source>Nature</source>. <year>2018</year>;<volume>562</volume>(<issue>7728</issue>):<fpage>583</fpage>&#8208;<lpage>588</lpage>.<pub-id pub-id-type="pmid">30356187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-018-0617-x</pub-id><pub-id pub-id-type="pmcid">PMC6415775</pub-id></mixed-citation></ref><ref id="pai70182-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="pai70182-cit-0020"><string-name name-style="western"><surname>Pannaraj</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Cerini</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Association between breast Milk bacterial communities and establishment and development of the infant gut microbiome</article-title>. <source>JAMA Pediatr</source>. <year>2017</year>;<volume>171</volume>(<issue>7</issue>):<fpage>647</fpage>&#8208;<lpage>654</lpage>.<pub-id pub-id-type="pmid">28492938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapediatrics.2017.0378</pub-id><pub-id pub-id-type="pmcid">PMC5710346</pub-id></mixed-citation></ref><ref id="pai70182-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="pai70182-cit-0021"><string-name name-style="western"><surname>Tsukuda</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Yahagi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hara</surname><given-names>T</given-names></string-name>, et&#160;al. <article-title>Key bacterial taxa and metabolic pathways affecting gut short&#8208;chain fatty acid profiles in early life</article-title>. <source>ISME J</source>. <year>2021</year>;<volume>15</volume>(<issue>9</issue>):<fpage>2574</fpage>&#8208;<lpage>2590</lpage>.<pub-id pub-id-type="pmid">33723382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41396-021-00937-7</pub-id><pub-id pub-id-type="pmcid">PMC8397723</pub-id></mixed-citation></ref><ref id="pai70182-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="pai70182-cit-0022"><string-name name-style="western"><surname>Pribyl</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Parks</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Angel</surname><given-names>NZ</given-names></string-name>, et&#160;al. <article-title>Critical evaluation of faecal microbiome preservation using metagenomic analysis</article-title>. <source>ISME Commun</source>. <year>2021</year>;<volume>1</volume>(<issue>1</issue>):<fpage>14</fpage>.<pub-id pub-id-type="pmid">37938632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43705-021-00014-2</pub-id><pub-id pub-id-type="pmcid">PMC9645250</pub-id></mixed-citation></ref><ref id="pai70182-bib-0023"><label>23</label><mixed-citation publication-type="miscellaneous" id="pai70182-cit-0023"><string-name name-style="western"><surname>Tang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Carr</surname><given-names>AV</given-names></string-name>, <string-name name-style="western"><surname>Perez</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Metagenomic estimation of absolute bacterial biomass in the mammalian gut through host&#8208;derived read normalization. bioRxivorg</article-title>. <year>2025</year>. doi:<pub-id pub-id-type="doi">10.1101/2025.01.07.631807</pub-id><pub-id pub-id-type="pmcid">PMC12363224</pub-id><pub-id pub-id-type="pmid">40742180</pub-id></mixed-citation></ref><ref id="pai70182-bib-0024"><label>24</label><mixed-citation publication-type="miscellaneous" id="pai70182-cit-0024"><string-name name-style="western"><surname>Oksanen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Blanchet</surname><given-names>FG</given-names></string-name>, <string-name name-style="western"><surname>Friendly</surname><given-names>M</given-names></string-name>. <article-title>vegan: Community Ecology Package. R package version 2.6&#8208;8</article-title>. <year>2024</year><ext-link xlink:href="https://cran.r-project.org/web/packages/vegan/vegan.pdf" ext-link-type="uri">https://cran.r&#8208;project.org/web/packages/vegan/vegan.pdf</ext-link></mixed-citation></ref><ref id="pai70182-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="pai70182-cit-0025"><string-name name-style="western"><surname>Mallick</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Rahnavard</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>McIver</surname><given-names>LJ</given-names></string-name>, et&#160;al. <article-title>Multivariable association discovery in population&#8208;scale meta&#8208;omics studies</article-title>. <source>PLoS Comput Biol</source>. <year>2021</year>;<volume>17</volume>(<issue>11</issue>):<elocation-id>e1009442</elocation-id>.<pub-id pub-id-type="pmid">34784344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pcbi.1009442</pub-id><pub-id pub-id-type="pmcid">PMC8714082</pub-id></mixed-citation></ref><ref id="pai70182-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="pai70182-cit-0026"><string-name name-style="western"><surname>Reyman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>van Houten</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Baarle</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>Impact of delivery mode&#8208;associated gut microbiota dynamics on health in the first year of life</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<elocation-id>4997</elocation-id>.<pub-id pub-id-type="pmid">31676793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-13014-7</pub-id><pub-id pub-id-type="pmcid">PMC6825150</pub-id></mixed-citation></ref><ref id="pai70182-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="pai70182-cit-0027"><string-name name-style="western"><surname>Silverberg</surname><given-names>JI</given-names></string-name>, <string-name name-style="western"><surname>Barbarot</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gadkari</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Atopic dermatitis in the pediatric population: a cross&#8208;sectional, international epidemiologic study</article-title>. <source>Ann Allergy Asthma Immunol</source>. <year>2021</year>;<volume>126</volume>(<issue>4</issue>):<fpage>417</fpage>&#8208;<lpage>428.e2</lpage>.<pub-id pub-id-type="pmid">33421555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.anai.2020.12.020</pub-id></mixed-citation></ref><ref id="pai70182-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="pai70182-cit-0028"><string-name name-style="western"><surname>Azad</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Konya</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Persaud</surname><given-names>RR</given-names></string-name>, et&#160;al. <article-title>Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study</article-title>. <source>BJOG</source>. <year>2016</year>;<volume>123</volume>(<issue>6</issue>):<fpage>983</fpage>&#8208;<lpage>993</lpage>.<pub-id pub-id-type="pmid">26412384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1471-0528.13601</pub-id></mixed-citation></ref><ref id="pai70182-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="pai70182-cit-0029"><string-name name-style="western"><surname>Ennis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Shmorak</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jantscher&#8208;Krenn</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Yassour</surname><given-names>M</given-names></string-name>. <article-title>Longitudinal quantification of bifidobacterium longum subsp. infantis reveals late colonization in the infant gut independent of maternal milk HMO composition</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>894</fpage>.<pub-id pub-id-type="pmid">38291346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-45209-y</pub-id><pub-id pub-id-type="pmcid">PMC10827747</pub-id></mixed-citation></ref><ref id="pai70182-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="pai70182-cit-0030"><string-name name-style="western"><surname>Sela</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Chapman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Adeuya</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>The genome sequence of bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2008</year>;<volume>105</volume>(<issue>48</issue>):<fpage>18964</fpage>&#8208;<lpage>18969</lpage>.<pub-id pub-id-type="pmid">19033196</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0809584105</pub-id><pub-id pub-id-type="pmcid">PMC2596198</pub-id></mixed-citation></ref><ref id="pai70182-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="pai70182-cit-0031"><string-name name-style="western"><surname>Frese</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Hutton</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Contreras</surname><given-names>LN</given-names></string-name>, et&#160;al. <article-title>Persistence of supplemented bifidobacterium longum subsp. infantis EVC001 in breastfed infants</article-title>. <source>mSphere</source>. <year>2017</year>;<volume>2</volume>(<issue>6</issue>):<elocation-id>e00501&#8208;17</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mSphere.00501-17</pub-id><pub-id pub-id-type="pmid">29242832</pub-id><pub-id pub-id-type="pmcid">PMC5717325</pub-id></mixed-citation></ref><ref id="pai70182-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="pai70182-cit-0032"><string-name name-style="western"><surname>Henrick</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Rodriguez</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lakshmikanth</surname><given-names>T</given-names></string-name>, et&#160;al. <article-title>Bifidobacteria&#8208;mediated immune system imprinting early in life</article-title>. <source>Cell</source>. <year>2021</year>;<volume>184</volume>(<issue>15</issue>):<fpage>3884</fpage>&#8208;<lpage>3898.e11</lpage>.<pub-id pub-id-type="pmid">34143954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2021.05.030</pub-id></mixed-citation></ref><ref id="pai70182-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="pai70182-cit-0033"><string-name name-style="western"><surname>Bunesova</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Lacroix</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schwab</surname><given-names>C</given-names></string-name>. <article-title>Fucosyllactose and L&#8208;fucose utilization of infant bifidobacterium longum and bifidobacterium kashiwanohense</article-title>. <source>BMC Microbiol</source>. <year>2016</year>;<volume>16</volume>(<issue>1</issue>):<fpage>248</fpage>.<pub-id pub-id-type="pmid">27782805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12866-016-0867-4</pub-id><pub-id pub-id-type="pmcid">PMC5080750</pub-id></mixed-citation></ref><ref id="pai70182-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="pai70182-cit-0034"><string-name name-style="western"><surname>Li</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Xue</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>An in&#160;vitro colonic fermentation study of the effects of human milk oligosaccharides on gut microbiota and short&#8208;chain fatty acid production in infants aged 0&#8208;6 months</article-title>. <source>Foods</source>. <year>2024</year>;<volume>13</volume>(<issue>6</issue>):<elocation-id>921</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/foods13060921</pub-id><pub-id pub-id-type="pmid">38540911</pub-id><pub-id pub-id-type="pmcid">PMC10970062</pub-id></mixed-citation></ref><ref id="pai70182-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="pai70182-cit-0035"><string-name name-style="western"><surname>Henrick</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Hutton</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Palumbo</surname><given-names>MC</given-names></string-name>, et&#160;al. <article-title>Elevated fecal pH indicates a profound change in the breastfed infant gut microbiome due to reduction of bifidobacterium over the past century</article-title>. <source>mSphere</source>. <year>2018</year>;<volume>3</volume>(<issue>2</issue>):<elocation-id>e00041&#8208;18</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mSphere.00041-18</pub-id><pub-id pub-id-type="pmid">29564397</pub-id><pub-id pub-id-type="pmcid">PMC5853487</pub-id></mixed-citation></ref><ref id="pai70182-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="pai70182-cit-0036"><string-name name-style="western"><surname>B&#228;ckhed</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Roswall</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Dynamics and stabilization of the human gut microbiome during the first year of life</article-title>. <source>Cell Host Microbe</source>. <year>2015</year>;<volume>17</volume>(<issue>5</issue>):<fpage>690</fpage>&#8208;<lpage>703</lpage>.<pub-id pub-id-type="pmid">25974306</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2015.04.004</pub-id></mixed-citation></ref><ref id="pai70182-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="pai70182-cit-0037"><string-name name-style="western"><surname>Stokholm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Blaser</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Thorsen</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Maturation of the gut microbiome and risk of asthma in childhood</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<elocation-id>141</elocation-id>.<pub-id pub-id-type="pmid">29321519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-017-02573-2</pub-id><pub-id pub-id-type="pmcid">PMC5762761</pub-id></mixed-citation></ref><ref id="pai70182-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="pai70182-cit-0038"><string-name name-style="western"><surname>Galazzo</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>van Best</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Bervoets</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood</article-title>. <source>Gastroenterology</source>. <year>2020</year>;<volume>158</volume>(<issue>6</issue>):<fpage>1584</fpage>&#8208;<lpage>1596</lpage>.<pub-id pub-id-type="pmid">31958431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2020.01.024</pub-id></mixed-citation></ref><ref id="pai70182-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="pai70182-cit-0039"><string-name name-style="western"><surname>Gong</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Effect of probiotic supplementation on the gut microbiota composition of infants delivered by cesarean section: an exploratory, randomized, open&#8208;label, parallel&#8208;controlled trial</article-title>. <source>Curr Microbiol</source>. <year>2023</year>;<volume>80</volume>(<issue>11</issue>):<fpage>341</fpage>.<pub-id pub-id-type="pmid">37712964</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00284-023-03444-4</pub-id></mixed-citation></ref><ref id="pai70182-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="pai70182-cit-0040"><string-name name-style="western"><surname>Bajorek</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Duar</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Corrigan</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>
<italic toggle="yes">B. infantis</italic> EVC001 is well&#8208;tolerated and improves human milk oligosaccharide utilization in preterm infants in the neonatal intensive care unit</article-title>. <source>Front Pediatr</source>. <year>2021</year>;<volume>9</volume>:<elocation-id>795970</elocation-id>.<pub-id pub-id-type="pmid">35071138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2021.795970</pub-id><pub-id pub-id-type="pmcid">PMC8767116</pub-id></mixed-citation></ref><ref id="pai70182-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="pai70182-cit-0041"><string-name name-style="western"><surname>Niers</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mart&#237;n</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rijkers</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>The effects of selected probiotic strains on the development of eczema (the PandA study)</article-title>. <source>Allergy</source>. <year>2009</year>;<volume>64</volume>(<issue>9</issue>):<fpage>1349</fpage>&#8208;<lpage>1358</lpage>.<pub-id pub-id-type="pmid">19392993</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1398-9995.2009.02021.x</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>